Perspective Therapeutics, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Perspective Therapeutics, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. Redefining Oncology Treatment with Next-Generation Radiopharmaceuticals Engineering the Alpha Advantage in Targeted Oncology Unlocking New Treatment Options Across Solid Tumors: Optimizing the Entire System Rapidly Advancing Best-in-Class Next Generation Radiopharmaceuticals Optimizing Structural Chemistry: Choosing The Right Isotope Not All ²¹&sup…